United Therapeutics, a Maryland and North Carolina corporation known for pig organ transplant work, is looking to build a ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

United Therapeutics Corporation (Nasdaq ... the timing and enrollment of our planned UKidney clinical trial; our plans to seek FDA approval of the UKidney following completion of the clinical ...

RESEARCH TRIANGLE PARK, N.C. - United Therapeutics (NASDAQ ... an investigational new drug application for the UKidney, with plans to initiate a clinical study in 2025, pending FDA clearance.

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...

The merger agreement, titled the Agreement and Plan of Merger and Reorganization ... and commercializing therapeutics treatment of chronic pruritus in the United States. The company’s lead ...

Apogee Therapeutics, Inc. (NASDAQ:APGE) had $754 million in cash and cash equivalents, promising smooth operations into 2028. The company plans to continue building its portfolio with ...

RESEARCH TRIANGLE PARK, N.C. - United Therapeutics (NASDAQ:UTHR ... The company is preparing an investigational new drug application for the UKidney, with plans to initiate a clinical study in 2025, ...

Cynata Therapeutics Limited ( OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET Lauren Nowak - Media Relations Kilian Kelly - Chief Executive Officer and Managing Director ...